UCLA Jonsson Comprehensive Cancer Center
@UCLAHealthJCCC
Followers
122
Following
173
Statuses
150
Official account for the UCLA Jonsson Comprehensive Cancer Center, a leader in cancer care, research and education.
Los Angeles, CA
Joined August 2024
RT @OncLive: @dradityabardia of @UCLAHealthJCCC presents real-world findings on elacestrant, demonstrating prolonged real-world progression…
0
1
0
Congratulations, Dr. Jung!
By advancing synthetic organic and medicinal #chemistry, Michael E. Jung's groundbreaking work has been instrumental to the treatment of prostate #cancer. For these efforts, he will receive the 2025 NAS Award for Chemistry in Service to Society. #NASaward
0
0
2
RT @CureMelanoma: This #MRFResearchWednesday, we’re spotlighting Dr. Prashanthi Dharanipragada, PhD, from @UCLAHealthJCCC, a recent MRF Car…
0
1
0
RT @UCLA: @UCLAHealthJCCC found that patients with early bowel side effects had nearly double the risk of chronic bowel issues. https://t.…
0
1
0
RT @UCLAHealth: Once thought untreatable, melanoma has met its toughest opponent: the body's immune system, enhanced by immunotherapies. Re…
0
3
0
Cancer touches many lives, from people with cancer to family & friends. In 2024, more than 2 million new cancer cases were diagnosed in the U.S. In recognition of #WorldCancerDay, please consider sharing some resources that could help you or a loved one:
0
0
0
Congratulations to Drs. Robert Prins & Ben Ellingson on receiving an @NIH grant to support the Neuro-Oncology Translational Research Training Program, an initiative designed to train the next generation of brain tumor scientists. Learn more:
0
0
5
RT @OncLive: Hear @dradityabardia discuss the FDA approval of Dato-DXd for pretreated, hormone receptor–positive, HER2-negative metastatic…
0
2
0
A UCLA study in @TheLancetOncol found prostate cancer patients experience very low rates of long-term complications from radiation treatment, however, those patients who have early side effects are more likely to sustain them long-term. Read more:
0
0
1
RT @PedramMD: We presented two studies at the @SIO_Central 2025 Meeting on ‘Machine Learning-Based Radiomic Features of Pre-LRT MRI and His…
0
3
0
RT @UrologyTimes: WATCH: Amar U. Kishan, MD, (@AmarUKishan) discusses the rationale for the initiation and design of the MIRAGE trial. @Ucl…
0
3
0
RT @AmarUKishan: Proud to share work led by John Nikitas PGY-5 @UCLAHealth out in @TheLancetOncol We leveraged…
0
19
0
RT @RadiologyUcla: In @OUPAcademic, @RadiologyUcla's Dr. Benjamin Ellingson discusses "the current state of the art & opportunities of targ…
0
2
0
Congrats to @ACovarrubiasPhD for receiving a $2M grant from the @NIH to study how aging cells drive cancer, neurodegenerative disorders & other conditions. Read more about his research here:
1
0
0
Congratulations to @ShiqinLiu1892 for receiving the Lung Cancer Concept Award from the @DeptofDefense to develop new immune-based treatments for small-cell lung cancer. Read more about Dr. Liu's research here:
0
1
5
RT @TeitellLab: Interested in mito transfer? Our lab and other leaders in the community came together to create a nomenclature review desc…
0
1
0
A new study led by UCLA researchers and published in @NatureComms reveals how blood vessel-tumor interactions fuel glioblastoma, offering insights for new strategies to combat the disease. Read about the findings here:
0
2
6
RT @CancerResearch: According to a new study from researchers at @UCLAHealth's Jonsson Comprehensive Cancer Center, "many cases of high-ris…
0
3
0
RT @UCLAHealth: Updated as of today, January 8th. Visit this page: We are closely monitoring developments, and the…
0
6
0